Perimenopause: The complex endocrinology of the menopausal transition

Endocrine Reviews

Volumn 19, Issue 4, 1998, Pages 397-428

  Prior, Jerilynn C ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b Division of Endocrinology   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN;

ANOVULATION; CLINICAL RESEARCH; COMORBIDITY; FEMALE; HISTOLOGY; HORMONE ACTION; HUMAN; LUTEAL PHASE; MENOPAUSE; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; OVARY HYPERSTIMULATION; PATHOPHYSIOLOGY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; REVIEW;

EID: 0032450106     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/edrv.19.4.0341     Document Type: Review

References (199)

1. Grady D, Rubin SM, Petitti DB, Fox CS, Black DM, Ettinger B, Ernster VL, Cummings SR 1992 Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117:1016-1037
2. Sowers MR, La Pietra MT 1995 Menopause: its epidemiology and potential association with chronic diseases. Epidemiol Rev 17:287-302
3. Lindsay R, Hart DM, Clark DM 1984 The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol 63:759-763
4. Cummings SR, Kelsey JL, Nevitt MC, O'Dowd KJ 1985 Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 7:178-208
5. Riis BJ, Christiansen C, Deftos LJ, Catherwood BD 1984 The role of serum concentrations of estrogen in postmenopausal osteoporosis and bone turnover. In: Christiansen C, Arnaud CD, Nordin BEC, Parfitt AM, Peck WA, Riggs BL (eds) Osteoporosis. Department of Clinical Chemistry, Glostrup Hospital, Glostrup, Denmark, pp 333-336
6. Tataryn IV, Lomax P, Bajorek JG, Chesarek W, Meldrum DR, Judd HL 1980 Postmenopausal hot flushes: a disorder of thermoregulation. Maturitas 2:101-107
7. Kaufert PA 1988 Menopause as a process or event: the creation of definitions in biomedicine. In: Lock M, Gordon D (eds) Biomedicine Examined. Kluwer Academic Press, Durdrecht, Germany, pp 331-349
8. Prior JC 1995 Menopause. In: Gray J (ed) Therapeutic Choices. Canadian Pharmaceutical Association, Ottawa, Ontario, Canada, pp 468-477
9. Kaufert PA, Lock M, McKinlay SB, Avis NE 1993 Menopause as a normal physiological event or as a disease. In: Lorrain J, Plouffe LJ, Ravnikar V, Watts N, Speroff L (eds) Comprehensive Management of Menopause. Springer Verlag, New York, pp 59-65
10. WHO Scientific Group 1996 Research on the menopause in the 1990's. A report of the WHO Scientific Group. World Health Organization, Geneva, Switzerland, vol 866:1-79
11. Nelson LM, Anasti JN, Flack MR 1996 Premature ovarian failure. In: Adashi EY, Rock JA, Rosenwacks Z (eds) Reproductive Endocrinology Surgery and Technology. Lippincott-Raven Publishers, Philadelphia, pp 1393-1410
12. American College of Physicians 1992 Guidelines for counselling postmenopausal women about preventive hormone therapy. Ann Intern Med 117:1038-1041
13. Taylor P, Fugere P, Jolly E 1994 Canadian Menopause Consensus Conference. J Soc Obstet Gynecol Can 16:4-39
14. Burger HG 1994 Diagnostic role of follicle-stimulating hormone (FSH) measurements during the menopausal transition - an analysis of FSH, oestradiol and inhibin. Eur J Endocrinol 130:38-42
15. Metcalf MG, Donald RA, Livesey JH 1981 Pituitary-ovarian function in normal women during the menopausal transition. Clin Endocrinol (Oxf) 14:245-255
16. Vollman RF 1977 The menstrual cycle. In: Friedman EA (ed) Major Problems in Obstetrics and Gynecology. W. B. Saunders Company, Toronto, vol 7:11-193
17. Lock M 1991 Medicine and culture: contested meanings of the menopause. Lancet 337:1270-1272
18. Haines CJ, Rong L, Chung TKH, Leung DHY 1995 The perception of the menopause and the climacteric among women in Hong Kong and Southern China. Prev Med 24:245-248
19. van Keep PA, Kellerhals JM 1974 The impact of socio-cultural factors on symptom formation. Some results of a study on ageing women in Switzerland. Psychother Psychosom 23:251-263
20. Lock M, Kaufert P, Gilbert P 1988 Cultural construction of the menopausal syndrome: the Japanese case. Maturitas 10:317-332
21. Kaufert P, Lock M, McKinlay S, Beyenne Y, Coope J, Davis D, Eliasson M, Gognalons-Nicolet M, Goodman M 1986 Menopause research: the Korpilampi workshop. Soc Sci Med 22:1285-1289
22. Brown JK 1982 A cross-cultural explanation of the end of the childbearing years. In: Voda AM, Dirrerstein M, O'Donnell SR (eds) Changing Perspectives and Menopause. University of Texas Press, Austin, TX, pp 51-59
23. Khaw KT 1992 Epidemiology of the menopause. Br Med Bull 48:249-261
24. Bromberger JT, Matthews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P 1997 Prospective study of the determinants of age at menopause. Am J Epidemiol 145:124-133
25. Goodman MJ, Grove JS, Gilbert F 1978 Age at menopause in relation to reproductive history in Japanese, Caucasian, Chinese and Hawaiian women living in Hawaii. J Gerontol 33:688-694
26. Brambilla DJ, McKinlay SM 1989 A prospective study of factors affecting age at menopause. J Clin Epidemiol 42:1031-1039
27. Siddle N, Sarrel P, Whitehead MI 1987 The effect of hysterectomy on the age at ovarian failure: identification of a subgroup of women with premature loss of ovarian function and literature reveiw. Fertil Steril 47:94-100
28. Matthews KA, Wing RR, Kuller LH, Meilahn EN, Plantinga P 1994 Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women. Arch Intern Med 154:2349-2355
29. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RK 1989 Menopause and risk factors for coronary heart disease. N Engl J Med 321:641-646
30. Fisher RA 1958 Statistical Methods for Research Workers, ed. 13, Hafner, New York pp 99-101
31. Burger HG, Dudley EC, Hopper JL, Shelley JM, Green A, Smith A, Dennerstein L, Morse C 1995 The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab 80:3537-3545
32. MacNaughton J, Banah M, McCloud PI, Hee JP, Burger HG 1992 Age related changes in follicule stimulating hormone, luteinizing hormone, oestradiol and immunoreactive inhibin in women of reproductive age. Clin Endocrinol (Oxf) 36:339-345
33. McLachlan RI, Robertson DM, Healy DL, Burger HG, de Kretser DM 1987 Circulating immunoreactive inhibin levels during the normal human menstrual cycle. J Clin Endocrinol Metab 65:954-961
34. Santoro N, Rosenberg J, Adel T, Skurnick JH 1996 Characterization of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab 81:1495-1501
35. Brown JB, Kellar R, Matthews GD 1959 Preliminary observations on urinary oestrogen excretion in certain gynaecological disorders. J Obstet Gynecol Br Commonw 66:177-211
36. Brown JB, Matthews GD 1962 The application of urinary estrogen measurements to problems in gynecology. Recent Prog Horm Res 18:337-373
37. Brown JB, Harrison P, Smith MA, Burger HG 1983 Correlation between the mucus symptoms and the hormonal markers of fertility throughout reproductive life. In: Billings JJ (ed) The Ovulation Method. Advocate Press Ltd, Melbourne, pp 99-125
38. Metcalf MG, MacKenzie JA 1985 Menstrual cycle and exposure to estrogens unopposed by progesterone: relevance to studies on breast cancer incidence. J Endocrinol 104:137-141
39. Prior JC 1994 The perimenopause: pathophysiology, symptoms and therapy. In: Medifacts Healthcare Communications (audio). Medifacts Groups Limited, Ottawa, Ontario, Canada
40. Kaufert PA, Gilbert P, Tate R1987 Defining menopausal status: the impact of longitudinal data. Maturitas 9:217-226
41. Kaufert PA, Syrotvik J 1981 Symptom reporting at menopause. Soc Sci Med 15E:185-193
42. McKinlay JB, McKinlay SM, Brambilla DJ 1987 The relative contribution of endocrine changes and social circumstances to depression in mid-aged women. J Health Soc Behav 28:345-363
43. Oldenhave A, Jaszmann JB, Haspels AA, Everaerd WTAM 1993 Impact of climacteric on well-being. Am J Obstet Gynecol 168:772-780
44. Brambilla DJ, McKinlay SM, Johannes CB 1994 Defining the perimenopause for application in epidemiologic investigations. Am J Epidemiol 140:1091-1095
45. McKinlay SM, Brambilla DJ, Posner JG 1992 The normal menopause transition. Maturitas 14:103-115
46. Tuppurainen M, Honkanen R, Kroger H, Saarikoski S, Alhava E 1993 Osteoporosis risk factors, gyneacological history and fractures in perimenopausal women - the results of the baseline postal enquiry of the Kupio osteoporosis risk factor and prevention study. Maturitas 17:89-100
47. Treloar AE, Boyton RE, Behn BG, Brown BW 1967 Variations of the human menstrual cycle through reproductive life. Int J Fertil 12:77-126
48. Treloar AE 1981 Menstrual cyclicity and the premenopause. Maturitas 3:249-264
49. Ebbiary NAA, Lenton EA, Cooke ID 1994 Hypothalamic-pituitary ageing: progressive increase in FSH an LH concentrations throughout reproductive life in regularly menstruating women. Clin Endocrinol (Oxf) 41:199-206
50. Dennerstein L, Smith AMA, Morse C, Burger H, Green A, Hopper J, Ryan M 1993 Menopausal symptoms in Australian women. Med J Aust 159:232-236
51. Wilbush J 1988 Menopause and menorrhagia: a historical exploration. Maturitas 10:83-108
52. Tilt EJ 1871 The Change of Life in Health and Disease. A Practical Treatise on the Nervous and Other Afflictions of Women at the Decline of Life. Lindsay & Blakiston, Philadelphia
53. Kupperman HS, Blatt MHG, Wiesbader H, Filler W 1953 Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J Clin Endocrinol Metab 13:688-703
54. Blatt MG, Wiesbader H, Kupperman HS 1953 Vitamin E and the climateric syndrome. Arch Intern Med 91:792-799
55. Neugarten BL, Kraines RJ 1964 Menopausal symptoms in women of various ages. Psychosom Med 27:266-273
56. Collett M 1949 Basal metabolism at the menopause. J Appl Physiol 1:629-636
57. Collett ME, Wertenberger GE, Fiske VM 1954 The effect of age upon the pattern of the menstrual cycle. Fertil Steril 5:437-448
58. Doring GK 1969 The incidence of anovular cycles in women. J Reprod Fertil [Suppl 6]:77-81
59. Chiazze L, Brayer FT, Macisco JJ, Parker MP, Duffy BJ 1968 The length and variability in the human menstrual cycle. J Am Med Assoc 203:377-380
60. Prior JC, Vigna YM, Schulzer M, Hall JE, Bonen A 1990 Determination of luteal phase length by quantitative basal temperature methods: validation against the midcycle LH peak. Clin Invest Med 13:123-131
61. Metcalf MG 1979 Incidence of ovulatory cycles in women approaching the menopause. J Biosoc Sci 11:39-48
62. Metcalf MG, Donald RA 1979 Fluctuating ovarian function in a perimenopausal women. NZ Med J 89:45-47
63. Van Look PF, Lothian H, Hunter WM, Michie EA, Baird DT 1977 Hypothalamic-pituitary-ovarian function in perimenopausal women. Clin Endocrinol (Oxf) 7:13-31
64. Sherman BM, Korenman SG 1975 Hormonal characteristics of the human menstrual cycle throughout reproductive life. J Clin Invest 55:699-706
65. Ballinger CB, Browning NC, Smith AHW 1987 Hormonal profiles and psychological symptoms in peri-menopausal women. Maturitas 9:235-251
66. Metcalf MG, Donald RA, Livesey JH 1981 Classification of menstrual cycles in pre and perimenopausal women. J Endocrinol (Oxf) 91:1-10
67. Kaufert PA 1980 The perimenopausal woman and her use of the health services. Maturitas 2:191-205
68. Kaufert PA 1982 Anthropology and the menopause: the development of a theoretical framework. Maturitas 4:181-193
69. Kaufert PA 1982 Myth and the menopause. Soc Health Illness 4:141-166
70. Kaufert PA 1984 Research note - women and their health in the middle years: a Manitoba project. Soc Sci Med 18:279-281
71. Kaufert PA, Gilbert P, Hassard T 1988 Researching the symptoms of menopause: an exercise in methodology. Maturitas 10:117-131
72. Lock M, Kaufert PA, Gilbert P 1988 Cultural construction of the menopausal syndrome: the Japanese case. Maturitas 10:317-332
73. Kaufert PA 1989 Aging, women and health. In: Clarke JN, Dorney L (eds) Women and Aging Conference - Interdisciplinary Research Seminar. Wilfred Laurier University, Waterloo, Ontario, Canada
74. Kaufert PA 1986 The menopausal transition; the use of estrogen. Can J Public Health 77[Suppl 1]:86-91
75. Kaufert PA, Gilbert P 1986 Women, menopause and medicalization. Cult Med Psychiatry 10:7-21
76. Kaufert PA, Gilbert P, Tate R 1992 The Manitoba Project: a reexamination of the link between menopause and depression. Maturitas 14:143-155
77. Kaufert PA 1990 Methodological issues in menopause research. In: Flint M, Kronenberg F, Utian W (eds) Multidisciplinary perspectives on menopause. Ann NY Acad Sci 592:114-122
78. Hemminki E, Kennedy DL, Baum C, McKinJay SM 1988 Prescribing of noncontraceptive estrogens and progestins in the United States 1974-1986. Am J Public Health 78:1479-1481
79. McKinlay SM, McKinlay JB: 1986 Health Status and Health Care Utilization by Menopausal Women. In: Mastrianni L, Paulsen CA (eds) Aging Reproduction and the Climacteric. Plenum Press, New York, pp 243-262
80. Avis NE, McKinlay SM 1991 A longitudinal analysis of women's attitudes toward the menopause: results from the Massachussets Women's Health Study. Maturitas 13:65-79
81. McKinlay SM, Brambilla DJ, Avis NE, McKinlay JB 1991 Mini symposium: women's experience of the menopause. Curr Probl Obstet Gynecol 1:3-7
82. Johannes CB, Crawford SL, Posner JG, McKinlay SM: 1994 Longitudinal patterns and correlates of hormone replacement therapy use in middle-aged women. Am J Epidemiol 140:439-452
83. Fraser IS, Baird DT 1972 Endometrial cystic glandular hyperplasia in adolescent girls. J Obstet Gynaecol 79:1009-1013
84. Rannevik G, Jeppson S, Johnell O, Bjerre B, Laurell-Borulf Y, Svanberg L 1995 A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. Maturitas 21:103-113
85. Guthrie JR, Dennerstein L, Hopper JL, Burger HG: 1996 Hot flushes, menstrual status, and hormone levels in a population-based sample of midlife women. Obstet Gynecol 88:437-442
86. Prior JC, Barr SI, Vigna YM 1996 The controversial endocrinology of the menopausal transition (letter). J Clin Endocrinol Metab 81: 3127-3128
87. Papanicolaou AD, Lorain JA, Dove GA, Loudon NB 1969 Hormone excretion patterns in perimenopausal women. J Obstet Gynaecol Br Commonw 76:308-316
88. Adamopoulas DA, Lorain JA, Dove GA 1971 Endocrinological studies in women approaching the menopause. J Obstet Gynaecol Br Commonw 78:62-79
89. Reyes FI, Winter JS, Faiman C 1977 Pituitary ovarian relationships preceding the menopause I. A cross-sectional study of serum follicle-stimulating hormone, luteinizing hormone, prolactin, estradiol and progesterone levels. Am J Obstet Gynecol 129:557-564
90. Abe T, Yama Y, Wada Y, Susuki M 1983 Pituitary-ovarian relationships in women approaching the menopause. Maturitas 5:31-37
91. Lee SJ, Lenton EA, Sexton L, Cooke ID 1988 The effect of age on the cyclical patterns of plasma LH, FSH, estradiol and progesterone in women with regular menstrual cycles. Hum Reprod 3:851-855
92. England PK, Skinner LG, Cottrile KM, Sellwood R 1974 Serum estradiol-17B in normal women. Br J Cancer 29:462-469
93. Sherman BM, West JH, Korenman SG 1976 The menopausal transition: analysis of LH, FSH, estradiol and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab 42:629-636
94. Metcalf MG, Livesey JH 1985 Gonadotropin excretion in fertile women: effect of age and the onset of the menopausal transition. J Endocrinol 105:357-362
95. Lind T, Cameron EC, Hunter WM, Leon C, Moran FP, Oxley A, Gerrard A, Lind UCG 1979 A prospective, continuous trial of six forms of hormone replacement therapy given to postmenopausal women. Br J Obstet Gynaecol 86[Suppl 3]: 1-29
96. Landgren BH, Unden AL, Diczfalusy E 1980 Hormonal profile of the cycle in 68 normally menstruating women. Acta Endocrinol (Copenh) 94:89-98
97. Demura R, Suzuki T, Mitsuhashi S, Odagiri E, Demura H, Ling N 1993 Human plasma free activin and inhibin levels during the menstrual cycle. J Clin Endocrinol Metab 76:1080-1082
98. Fitzgerald CT, Seif MW, Killick SR, Bennett DA 1994 Age related changes in the female reproductive cycle. Br J Obstet Gynaecol 101:229-233
99. Reame NE, Kelch RP, Bietins IZ, Yu M-Y, Zawacki CM, Padmanabhan V 1996 Age effects on follicle-stimulating hormone and pulsatile luteinizing hormone secretion across the menstrual cycle of premenopausal women. J Clin Endocrinol Metab 81:1512-1518
100. Klein NA, Illingworth PJ, Groome NP, McNeilly AS, Battaglia AS, Soules MR 1996 Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab 81:7:2742-2745
101. Prior JC, Vigna YM, Schechter MT, Burgess AE 1990 Spinal bone loss and ovulatory disturbances. N Engl J Med 323:1221-1227
102. Brown JB 1985 Return of fertility after childbirth and during lactation, and changes in the climacteric. J Bios Sci [Suppl 9]:5-27
103. Longcope C, Franz C, Morello C, Baker RS, Johnston CC 1986 Steroid and gonadotropin levels in women during the perimenopausal years. Maturitas 8:189-196
104. Shideler SE, DeVane GW, Kalra PS, Benirschke K, Lasley BL 1989 Ovarian-pituitary hormone interactions during the perimenopause. Maturitas 11:331-339
105. Billings EL, Brown JB, Billings JJ, Burger HG 1972 Symptoms and hormonal changes accompanying ovulation. Lancet 1:282-284
106. Hilgers TW, Abraham GE, Cavanagh D 1978 Natural family planning. I. The peak symptom and estimated time of ovulation. Obstet Gynecol 52:575-582
107. Pfeffer RI 1978 Estrogen use, hypertension and stroke in postmenopausal women. J Chronic Dis 31:389-398
108. Vermeulen A 1976 Postmenopausal ovarian function. In: James VH, Serio M, Giusti G (eds) The Endocrine Function of the Human Ovary. Academic Press, Inc., London, pp 237-244
109. Steger RW, Peluso JJ 1987 Sex hormones in the aging female. Endocrinol Metab Clin North Am 16:1027-1043
110. Baker TG 1963 A quantitative and cytological study of germ cells in human ovaries. Proc R Soc Med 158:417-433
111. Richardson SJ, Senikas V, Nelson JF 1987 Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 65:1231-1237
112. Block E 1952 Quantitative morphological investigations of the follicular system in women. Variations in different ages. Acta Anat (Basel) 14:108-123
113. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF 1992 Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 7:1342-1346
114. Nicosia SV 1986 Ovarian changes during the climacteric. In: Mastrioianni L, Paulsen CA (eds) Aging, Reproduction, and Climacteric. Plenum Press, New York, pp 179-199
115. McLachlan RI, Robertson DM, Healy DL, de Kretser DM, Burger HG 1986 Plasma inhibin levels during gonadotropin-induced ovarian hyperstimulation for IVF: a new index of follicular function? Lancet 1:1233-1234
116. Seifer DB, Gardiner AC, Lambert-Messerlian G, Schneyer AL 1996 Differential secretion of dimeric inhibin in cultured luteinized granulosa cells as a function of ovarian reserve. J Clin Endocrinol Metab 81:7:736-739
117. Hughes EG, Robertson DM, Handelsman DJ, Hayward S, Healy DL, DeKrester DM 1990 Inhibin and estradiol responses to ovarian hyperstimulation: effects of age and predictive value for in vitro fertilization outcome. J Clin Endocrinol Metab 70:358-364
118. Findlay JK, Xiao S, Shukovski L 1990 The role of inhibin-related peptides as intragonadal regulators. Reprod Fertil Dev 2:205-218
119. Romeu A, Muasher SJ, Acosta AA, Veeck LL, Diaz J, Jones GS, Jones Jr HW, Rosenwaks Z 1987 Results of in vitro fertilization attempts in women 40 years of age and older: the Norfolk experience. Fertil Steril 47:130-136
120. Martin JSB, Nisker JA, Tummon IS, Daniel SAJ, Auckland JL, Feyles V 1996 Future in vitro fertilization pregnancy potential of women with variably elevated day 3 follicle-stimulating hormone levels. Fertil Steril 65:1238-1240
121. Licciardi FL, Liu HC, Rosenwaks Z 1995 Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization. Fertil Steril 64:991-994
122. Smotrich DB, Widra EA, Gindoff PR, Levy MJ, Hall JL, Stillman RJ 1995 Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertil Steril 64:136-1140
123. Burger HG 1993 Editorial: Clinical utility of inhibin measurements. J Clin Endocrinol Metab 76:1391-1396
124. Hee JP, MacNaughton J, Bangah M, Zissimos M, McCloud PI, Healy DL, Burger HG 1993 Follicle-stimulating hormone induces dose-dependent stimulation of immunoreactive inhibin secretion during the follicular phase of the human menstrual cycle. J Clin Endocrinol Metab 76:1340-1343
125. Buckler HM, Evans CA, Mamtora H, Burger HG, Anderson DC 1991 Gonadotropin, steroid, and inhibin levels in women with incipient ovarian failure during anovulatory and ovulatory rebound cycles. J Clin Endocrinol Metab 72:116-124
126. Hee JP, MacNaughton J, Bangah M, Burger HG: 1993 Perimenopausal patterns of gonadotrophins, immunoreactive inhibin, oestradiol and progesterone. Maturitas 18:9-20
127. Gilfillan CP, Robertson DM, Burger HG, Leoni MA, Hurley VA, Martin NG 1996 The control of ovulation in mothers of dizygotic twins. J Clin Endocrinol Metab 81:4:1557-1562
128. Djerassi A, Coutifaris C, West VA, Asa SL, Kapoor SC, Pavlou SN, Snyder PJ 1945 Gonadotroph adenoma in a premenopausal woman secreting follicle-stimulating hormone and causing ovarian hyperstimulation. J Clin Endocrinol Metab 80:591-594
129. Lenton EA, Landgren BH, Sexton L, Harper R 1984 Normal variation in the length of the follicular phase of the menstrual cycle: effect of chronological age. BrJ Obstet Gynaecol 91:681-684
130. Prior JC 1994 One voice on menopause. J Am Med Worn Assoc 49:27-29
131. Oldenhave A, Netelenbos C 1994 Pathogenesis of climacteric complaints: ready for change? Lancet 343:649-653
132. Pacifici R, Rupich R, Griffin M, Chines A, Susman N, Avioli LV 1990 Dual energy radiography vs. quantitative computer tomography for the diagnosis of osteoporosis. J Clin Endocrinol Metab 70:705-710
133. Heilbrun LK, Russ PD, Wasnich RD, Yano K, Vogel JM 1991 Characteristics of respondents and nonrespondents in a prospective study of osteoporosis. J Clin Epidemiol 44:233-239
134. Moscarello R, Margittai KJ, Rossi M 1994 Differences in abuse reported by female and male Canadian medical students. Can Med Assoc J 150:357-362
135. Prior JC 1997 Ovulatory disturbances: they do matter. Can J Diagnosis February: 64-80
136. Hirvonen E, Malkonen M, Manninen V 1981 Effects of different progestogens on lipoproteins during postmenopausal replacement therapy. N Engl J Med 304:560-563
137. Gangar KF, Cust MP, Whitehead MI 1993 Symptoms of oestrogen deficiency associated with supraphysiological plasma estradiol concentrations in women with oestradiol implants. Br Med J 299: 601-602
138. Meldrum DR, Shamonki IM, Freeman AM, Tataryn IV, Chang RJ, Judd HL 1979 Elevations in skin temperature of the finger as an objective index of postmenopausal hot flashes: standardization of the technique. Am J Obstet Gynecol 135:713-717
139. Kronenberg F 1990 Hot flashes: epidemiology and physiology. Ann NY Acad Sci 592:52-86
140. Albright F 1936 Studies in ovarian dysfunction. III. The menopause. Endocrinology 20:24-31
141. Purdie DW, Steel SA, Howey S, Doherty SM 1996 Behaviour in HRT treated and untreated perimenopausal women. J Bone Miner Res 11S:(Abstract 450)
142. Schiff I, Regestein Q, Tulchinsky D, Ryan KJ 1979 Effects of estrogens on sleep and psychological state of hypogonadal women. J Am Med Assoc 242:2405-2407
143. Steingold KA, Laufer L, Chetkowski RJ, DeFazio J, Matt DW, Meldrum DR, Judd HL 1985 Treatment of hot flushes with transdermal estradiol administration. J Clin Endocrinol Metab 61:627-632
144. Bider D, Ben-Rafael Z, Shalev J, Mashiach S, Blankstein J 1989 Hot flushes during GnRH analogue administration despite normal serum oestradiol levels. Maturitas 11:223-228
145. Ginsburg J, Hardiman P 1989 Oestrogen deficiency and oestradiol implants (letter). Br Med J 229:1031-1031
146. Casper RF, Graves GR, Reid RL 1987 Objective measurement of hot flushes associated with the premenstrual syndrome. Fertil Steril 47:341-344
147. Groeneveld FPMJ, Bareman FP, Barentsen R, Dokter HJ, Drogendijk AC, Hoes AW 1996 Vasomotor symptoms and well-being in the climacteric years. Maturitas 23:293-299
148. Hammarback S, Damber J, Backstrom T 1989 Relatiohship between symptom severity and hormone changes in women with premenstrual syndrome. J Clin Endocrinol Metab 68:125-130
149. Wang M, Seippel L, Purdy RH, Backstrom T 1996 Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, prenenolone sulfate, 5a-Pregnane-3,20-Dione, and 3a-Hydroxy-5a-Pregnan-20-one. J Clin Endocrin Metab 81:1076-1082
150. Schiff I, Tulchinsky D, Cramer D, Ryan KJ 1980 Oral medroxy-progesterone in the treatment of postmenopausal symptoms. J Am Med Assoc 244:1443-1445
151. Prior JC, Alojado N, Vigna YM, Barr SI, McKay DW, Estrogen and progestin are equally effective in symptom control post-ovariectomy-a one-year, double-blind, randomized trial in premenopausal women. Program of the 76th Annual Meeting of The Endocrine Society, Anaheim, CA, 1994 (Abstract 12H), p 411
152. Torgerson DJ, Garton MJ, Reid DM 1993 Falling and perimenopausal women. Age Ageing 22:59-64
153. Prior JC, Alojado N, McKay DW, Vigna YM 1994 No adverse effects of medroxyprogesterone treatment without estrogen in postmenopausal women: double-blind, placebo-controlled, cross-over trial. Obstet Gynecol 83:24-28
154. American College of Obstetricians and Gynecologists 1986 Estrogen replacement therapy. Am Coll Obstet Gynecol Tech Bull 93:1-7
155. Riggs BL, Wahner HW, Seeman E, Offord KP, Dunn WL, Mazess RB, Johnson KA, Melton LJ 1982 Changes in bone mineral density of the proximal femur and spine with aging: differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest 70:716-723
156. Hui SL, Slemenda CW, Johnston Jr CC, Appledorn CR 1987 Effects of age and menopause on vertebral bone density. Bone Miner 2:141-146
157. Eastell R, Wahner HW, O'Fallon WM, Amadio PC, Melton LJ, Riggs BL 1989 Unequal decrease in bone density of lumbar spine and ultradistal radius in Colles' and vertebral fracture syndromes. J Clin Invest 83:168-174
158. Prior JC, Vigna YM, Barr SI, Kennedy S, Schulzer M, Li DK 1996 Ovulatory premenopausal women lose cancellous spinal bone: a five year prospective study. Bone 18:261-267
159. Ebeling PR, Atley LM, Guthrie JR, Burger HG, Dennerstein L, Hopper JL, Wark JD 1996 Bone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab 81:9: 3366-3371
160. Salamone LM, Glynn N, Black D, Epstein RS, Palermo L, Meilahn E, Kuller LH, Cauley JA 1995 Body composition and bone mineral density in premenopausal and early perimenopausal women. J Bone Miner Res 10:1762-1768
161. Salamone LM, Glynn NW, Black DM, Ferrell RE, Palermo L, Epstein RS, Kuller LH, Cauley JA 1996 Determinants of premenopausal bone mineral density: the interplay of genetic and lifestyle factors. J Bone Miner Res 11:1557-1565
162. Kroger H, Huopio J, Honkanen R, Tuppurainen M, Puntila E, Alhava E, Saarikoski S 1995 Prediction of fracture risk using axial bone mineral density in a perimenopausal population: a prospective study. J Bone Miner Res 10:302-306
163. Kroger H, Tuppurainen M, Honkanen R, Alhava E, Saarikoski S 1994 Bone mineral density and risk factors for osteoporosis - a population-based study of 1600 perimenopausal women. Calcif Tissue Int 55:1-7
164. Honkanen R, Kroger H, Tuppurainen M, Alhava E, Saarikoski S 1995 Fractures and low axial bone density in perimenopausal women. J Clin Epidemiol 48:881-888
165. Szejnfeld VL, Atra E, Baracat EC, Aldrighi JM, Civitelli R 1995 Bone density in white Brazilian women: rapid bone loss at the time around the menopause. Calcif Tissue Int 56:186-191
166. Christiansen C, Christensen MS, McNair P, Hagen C, Stocklund K, Transbol 1 1980 Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur J Clin Endocrinol 10:273-279
167. Sowers MF, Clark MK, Hollis BW, Wallace RB, Jannausch M 1992 Radial bone mineral density in pre- and perimenopausal women: prospective study of rates and risk factors for loss. J Bone Miner Res 6:647-657
168. Recker RR, Lappe JM, Davies KM, Kimmel DB 1992 Change in bone mass immediately before menopause. J Bone Miner Res 7:857-862
169. McClung M, Clemmesen B, Daifotis A, Gilchrist NL, Eisman JA, Weinstein RS, El Hajj Fuleihan G, Reda C, Yates AJ, Ravn P 1998 Alendronate prevents postmenopausal bone loss in women without osteoporosis. Ann Intern Med 128:253-261
170. Hosking DJ, Chilvers CE, Christiansen C, Ravn P, Wasnich R, Ross P, McClung M, Balske A, Thompson D, Daley M, Yates AJ 1998 Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. N Engl J Med 338:485-492
171. Nilas L, Christiansen C 1989 The pathophysiology of peri and postmenopausal bone loss. Br J Obstet Gynaecol 96:580-587
172. Elders PJM, Netelenbos JC, Lips P, van Ginkel FC, Khoe E, Leeuwenkamp OR, Hackeng WH, van der Stelt PF 1991 Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age. J Clin Endocrinol Metab 73:533-540
173. Pouilles JM, Tremollieres FA, Ribot C 1993 The effects of menopause on longitudinal bone loss from the spine. Calcif Tissue Int 52:340-343
174. Tsunenari T, Yamada S, Kawakatsu M, Negishi H, Tsutsumi M 1995 Menopause-related changes in bone mineral density in Japanese women: a longitudinal study on lumbar spine and proximal femur. Calcif Tissue Int 56:5-10
175. Perrone G, Galoppi P, Capri O, Anelli G, Borrelo M, Zichella L 1995 Lumbar and femoral bone density in perimenopausal women with irregular cycles. Int J Fertil 40:120-125
176. Ruiz JC, Tamborini P, Neftel P, Goux B 1995 Variabilite de la reponse osseuse a l'instauration d'une hormonetherapie substitutive. Expansion Scientifique Francaise 90:263-274
177. Slemenda C, Longcope C, Peacock M, Johnston C, Hui S 1996 Sex steroids, bone mass and bone loss. J Clin Invest 97:14-21
178. Henzell S, Hickling C, Brayshaw J, Gutteridge D, Prince R, Nicholson G, Price R 1990 Dual energy digital x-ray densitometry: evidence for age-related bone loss in normal premenopausal women. Bone Miner 10:[Suppl]S298
179. Page L 1994 Menopause and Emotions: Making Sense of your Feelings When Your Feelings Make No Sense. Primavera Press, Vancouver, British Columbia, Canada, pp 1-241
180. Gambacciani M, Spinetti A, Taponeco F, Cappagli B, Maffei S, Maretti P, Piagesi L, Fioretti P 1994 Bone loss in perimenopausal women: a longitudinal study. Maturitas 18:191-197
181. Hassager C, Colwell A, Assiri AM, Eastell R, Russell RG, Christiansen C 1992 Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links: a longitudinal and cross-sectional study. Clin Endocrinol (Oxf) 37:45-50
182. Uebelhart D, Schlemmer A, Johanansen JS, Gineyts E, Christiansen C, Delmas PD 1991 Effect of menopause and hormone replacement on the urinary excretion of pyridinium cross-links. J Clin Endocrinol Metab 72:367-373
183. Emerentia CH, van Beresteijn MA, Van't Huq GS, de Waard H, Duvrsma SA 1990 Habitual dietary calcium intake and cortical bone loss in perimenopausal women: a longitudinal study. Calcif Tissue Int 47:338-344
184. Hanson DA, Weis MA, Bollen A-M, Maslan SL, Singer FR, Eyre DR 1992 A specific immunoassay for monitoring human bone resorption: quantitation of Type 1 collagen cross-linked N-Telopeptides in urine. J Bone Miner Res 7:1251-1258
185. Fujii Y, Goto B, Takahashi K, Fujita T 1994 Ultrasound transmission as sensitive indicator of bone change in Japanese women in the perimenopausal period. Bone Miner 25:93-101
186. Massie A, Porter RW 1993 Screening for osteoporosis: comparison between dual energy x-ray absorptiometry and broadband ultrasound attenuation in 1000 perimenopausal women. Osteoporos Int 3:107-110
187. Torgerson DJ, Campbell MK, Thomas RE, Reid DM 1996 Prediction of perimenopausal fractures by bone mineral density and other risk factors. J Bone Miner Res 11:293-297
188. Parfitt AM 1987 Trabecular bone architecture in the pathogenesis and prevention of fracture. Am J Med 82:68-72
189. Prior JC, Vigna YM, Lentle BC, Barr SI, Wattie A, Kazanjian A 1996 Population-based bone data from the Vancouver pilot of Canadian Multicentre Osteoporosis Study. J Bone Miner Res 11: 361(Abstract)
190. Tenenhouse A, Brown J, Joseph L, CAMOS Research Group 1997 Peak bone mass and prevalence of osteoporosis in a randomly selected Canadian population of men and women. J Bone Miner Res 12:T579
191. Ross PD, Davis JW, Vogel JM, Wasnich RD 1990 A critical review of bone mass and risk of fractures in osteoporosis. Calcif Tissue Int 46:149-161
192. Shostak M 1981 Nisa: The Life and Words of a !Kung Woman. Vintage Books, New York, pp 1-402
193. Kirschbaum C, Schommer N, Federenko I, Gaab J, Neumann O, Oellers M, Rohleder N, Untiedt A, Hanker J 1996 Short-term estradiol treatment enhances pituitary-adrenal axis and sympathetic responses to psyhosocial stress in healthy young men. J Clin Endocrinol Metab 81:3639-3643
194. Sherman SS, Neer R, Greendale G, Sowers MF, Gold E, Matthews K, McKinlay
195. Prior JC 1996 Exercise-associated menstrual disturbances. In: Adashi EY, Rock JA, Rosenwaks Z (eds) Reproductive Endocrinology, Surgery and Technology. Raven Press, New York, pp 1077-1091
196. Cutler WB, Garcia CR, McCoy N 1987 Perimenopausal sexuality. Arch Sex Behav 16:3:225-234
197. Cramer DW, Xu H, Harlow BL 1995 Family history as a predictor of early menopause. Fertil Steril 61:740-745
198. Elders PJM, Netelenbos JC, Lips P, Khoe E, van Ginkel FC, Hulshof KM, van der Stelt PF 1989 Perimenopausal bone mass and risk factors. Bone Miner 7:289-299
199. Iki M, Kajita E, Dohi Y, Nishino H, Kusaka Y, Tsuchida C, Yamamoto K, Ishii Y 1996 Age, menopause, bone turnover markers and lumbar bone loss in healthy Japanese women. Maturitas 25:59-67